Alerts will be sent to your verified email
Verify Email
STAR
|
Strides Pharma Scien
|
Marksans Pharma
|
FDC
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.7 % | 17.57 % | 13.66 % |
|
5yr Avg Net Profit Margin
|
12.9 % | 14.56 % | 16.24 % |
|
Price to Book
|
3.24 | 3.09 | 3.26 |
|
P/E
|
22.78 | 21.74 | 27.65 |
|
5yr Avg Cash Conversion Cycle
|
-51.45 Days | 71.65 Days | -14.0 Days |
|
5yr Average Interest Coverage Ratio
|
0.72 | 38.03 | 90.41 |
|
5yr Avg ROCE
|
10.5 % | 21.95 % | 14.95 % |
|
5yr Avg Operating Profit Margin
|
12.17 % | 20.32 % | 18.97 % |
|
5 yr average Debt to Equity
|
1.01 | 0.02 | 0.0 |
|
5yr CAGR Net Profit
|
68.01 % | 10.03 % | -2.41 % |
|
5yr Average Return on Assets
|
10.97 % | 13.19 % | 8.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.3 % | 43.87 % | 69.66 % |
|
Share Pledged by Promoters
|
50.1 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.07 % | -4.38 % | 0.16 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.99 % | 2.6 % | 1.1 % |
|
Strides Pharma Scien
|
Marksans Pharma
|
FDC
|
|---|